Havemeyer Place’s Repligen RGEN Stock Holding History

Havemeyer Place’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.46M	Buy	10,703 +6,575	+159%	+$808K	0.14%	238
2026 Q1	$486K	Buy	+4,128	New	+$577K	0.06%	403

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Havemeyer Place's RGEN Position: Q2 2026 in Review

Havemeyer Place increased its Repligen (RGEN) stake by 159% in Q2 2026, buying an estimated $808K and bringing the position to 10,703 shares worth $1.46M. The position accounts for 0.14% of the portfolio, ranked #238.

Havemeyer Place first reported a position in RGEN in Q1 2026 and has held it in 2 quarters since. 478 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

Havemeyer Place held 10,703 shares of Repligen worth $1.46M as of Q2 2026.
Havemeyer Place bought 6,575 Repligen shares in Q2 2026, an estimated $808K.
Repligen made up 0.14% of Havemeyer Place's portfolio in Q2 2026, its #238 holding.
Havemeyer Place first reported a position in Repligen in Q1 2026 and has held it in 2 quarters since.
478 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Havemeyer Place's 13F filing for Q2 2026, filed 13 Aug 2026.